CONMED Corporation: Organic Growth Is Masked By Divestitures (NYSE:CNMD)
· seekingalpha.com
Conmed's headline growth appeared flat at $343 million in the last quarter, but organic growth actually increased by 6%, with the leading segment being the...
As I was screening through medtech companies, I happened to stumble upon a stock that has been recently outperforming its industry and peer group, driven by imp...